IF staining and FACS analysis showed that PKP3 silencing was sufficient to abrogate the circIGF2BP3 overexpression-elicited decrease in the CD8+ TIL population and suppressed activated CD8+ T cells in the tumor region (Fig. 4N-O). The gene discussed is PKP3; the disease is neoplasm.